Argent Trust Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Buy
25,095
+1,943
+8% +$1.05M 0.42% 53
2025
Q4
$13.4M Buy
23,152
+1,581
+7% +$894K 0.46% 48
2025
Q3
$10.5M Buy
21,571
+1,125
+6% +$524K 0.37% 67
2025
Q2
$8.29M Sell
20,446
-1,522
-7% -$636K 0.31% 69
2025
Q1
$10.9M Buy
21,968
+28
+0.1% +$15.2K 0.45% 54
2024
Q4
$11.4M Sell
21,940
-643
-3% -$354K 0.47% 51
2024
Q3
$14M Buy
22,583
+31
+0.1% +$18.4K 0.58% 42
2024
Q2
$12.5M Buy
22,552
+551
+3% +$316K 0.55% 43
2024
Q1
$12.8M Buy
22,001
+569
+3% +$319K 0.58% 43
2023
Q4
$11.4M Sell
21,432
-141
-0.7% -$68.2K 0.57% 42
2023
Q3
$10.9M Buy
21,573
+197
+0.9% +$105K 0.6% 39
2023
Q2
$11.2M Buy
21,376
+1,280
+6% +$691K 0.6% 37
2023
Q1
$11.6M Buy
20,096
+222
+1% +$125K 0.73% 30
2022
Q4
$10.9M Buy
19,874
+179
+0.9% +$94.8K 0.72% 32
2022
Q3
$9.99M Buy
19,695
+16
+0.1% +$8.95K 0.72% 31
2022
Q2
$10.7M Sell
19,679
-80
-0.4% -$44K 0.73% 32
2022
Q1
$11.7M Sell
19,759
-293
-1% -$168K 0.71% 33
2021
Q4
$13.4M Buy
20,052
+83
+0.4% +$51.8K 0.78% 28
2021
Q3
$11.4M Buy
19,969
+685
+4% +$376K 0.73% 33
2021
Q2
$9.73M Sell
19,284
-266
-1% -$126K 0.64% 41
2021
Q1
$8.92M Buy
19,550
+537
+3% +$256K 0.63% 44
2020
Q4
$8.86M Sell
19,013
-191
-1% -$89.6K 0.68% 41
2020
Q3
$8.48M Sell
19,204
-185
-1% -$76.4K 0.75% 37
2020
Q2
$7.03M Buy
19,389
+68
+0.4% +$22.8K 0.66% 40
2020
Q1
$5.48M Buy
19,321
+62
+0.3% +$19.6K 0.62% 41
2019
Q4
$6.26M Buy
19,259
+438
+2% +$133K 0.56% 47
2019
Q3
$5.48M Buy
18,821
+1,547
+9% +$443K 0.53% 51
2019
Q2
$5.07M Buy
17,274
+567
+3% +$156K 0.51% 51
2019
Q1
$4.57M Sell
16,707
-4,211
-20% -$1.05M 0.48% 54
2018
Q4
$4.68M Buy
20,918
+550
+3% +$129K 0.55% 47
2018
Q3
$4.93M Sell
20,368
-895
-4% -$206K 0.57% 45
2018
Q2
$4.4M Buy
21,263
+11,898
+127% +$2.53M 0.54% 48
2018
Q1
$1.93M Sell
9,365
-467
-5% -$98K 0.55% 48
2017
Q4
$1.87M Sell
9,832
-215
-2% -$41.2K 0.73% 35
2017
Q3
$1.9M Sell
10,047
-91
-0.9% -$16.5K 0.75% 33
2017
Q2
$1.77M Sell
10,138
-674
-6% -$113K 0.73% 36
2017
Q1
$1.66M Buy
10,812
+144
+1% +$22K 0.69% 37
2016
Q4
$1.51M Sell
10,668
-248
-2% -$36.6K 0.67% 44
2016
Q3
$1.74M Sell
10,916
-229
-2% -$35.3K 0.74% 38
2016
Q2
$1.65M Buy
11,145
+510
+5% +$75.3K 0.72% 37
2016
Q1
$1.51M Sell
10,635
-158
-1% -$21.2K 0.73% 40
2015
Q4
$1.53M Buy
10,793
+174
+2% +$23.2K 0.76% 37
2015
Q3
$1.3M Buy
10,619
+80
+0.8% +$10.4K 0.74% 40
2015
Q2
$1.37M Buy
10,539
+657
+7% +$85.7K 0.69% 39
2015
Q1
$1.33M Sell
9,882
-22
-0.2% -$2.84K 0.67% 39
2014
Q4
$1.24M Buy
+9,904
New +$1.2M 0.75% 35

Other funds holding TMO

Argent Trust Co's TMO Position: Q1 2026 in Review

Argent Trust Co increased its Thermo Fisher Scientific (TMO) stake by 8.4% in Q1 2026, buying an estimated $1.05M and bringing the position to 25,095 shares worth $12.3M. The position accounts for 0.42% of the portfolio, ranked #53.

Argent Trust Co first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $14M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Argent Trust Co held 25,095 shares of Thermo Fisher Scientific worth $12.3M as of Q1 2026.
  • Argent Trust Co bought 1,943 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.05M.
  • Thermo Fisher Scientific made up 0.42% of Argent Trust Co's portfolio in Q1 2026, its #53 holding.
  • Argent Trust Co first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
  • Argent Trust Co's Thermo Fisher Scientific position peaked at $14M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.